Cart
sales@molnova.com
Home - Products - Chromatin/Epigenetic - Epigenetic Reader Domain - 3-methyl-1,2-dihydroquinolin-2-one

3-methyl-1,2-dihydroquinolin-2-one

CAS No. 2721-59-7

3-methyl-1,2-dihydroquinolin-2-one( —— )

Catalog No. M28403 CAS No. 2721-59-7

3-methyl-1,2-dihydroquinolin-2-one is the first known micromolar inhibitors of the ATAD2 bromodomain.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 56 In Stock
5MG 70 In Stock
10MG 105 In Stock
25MG 179 In Stock
50MG 258 In Stock
100MG 365 In Stock
200MG 496 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    3-methyl-1,2-dihydroquinolin-2-one
  • Note
    Research use only, not for human use.
  • Brief Description
    3-methyl-1,2-dihydroquinolin-2-one is the first known micromolar inhibitors of the ATAD2 bromodomain.
  • Description
    3-methyl-1,2-dihydroquinolin-2-one is the first known micromolar inhibitors of the ATAD2 bromodomain.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2721-59-7
  • Formula Weight
    159.188
  • Molecular Formula
    C10H9NO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc1cc2ccccc2[nH]c1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Eyer P, Hell W. The metabolism of 3-benzoylpyridine. Xenobiotica. 1983 Nov;13(11):649-59. PubMed PMID: 6673376.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • GSK778 hydrochloride

    GSK778 hydrochloride hydrochloride is a potent and selective BD1 bromodomain inhibitor of the BET proteins, with IC50s of 75 nM (BRD2 BD1), 41 nM (BRD3 BD1), 41 nM (BRD4 BD1), and 143 nM (BRDT BD1), respectively.

  • ZEN-3694

    ZEN-3694 (ZEN 3694) is a bromo-structural domain extra-terminal inhibitor (BETi) with activity in androgen signaling inhibitor (ASI) resistance models and can be used in combination with enzalutamide to study metastatic desmoplasia-resistant prostate cancer.

  • WAY-309060

    WAY-309060 is a BRD4 small molecule inhibitor with antitumor activity.

Sign In Join Free